Virus Pandemics and Vaccinations
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 1 September 2025 | Viewed by 256
Special Issue Editors
Interests: public health; vaccines; prevention; infectious diseases; vaccine hesitancy
Interests: public health; vaccines; prevention; infectious diseases; one health; vaccine hesitancy
Special Issues, Collections and Topics in MDPI journals
Interests: public health; vaccines; prevention; infectious diseases; prevention and protection at work; mass gathering and public health risks
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
While the COVID-19 pandemic is far from being really over, new health threats are continuously emerging, particularly from the interface between human beings, animals, insects, and the ever-changing environmental landscape of the post-globalization world. In such a setting, not only new and effective vaccine strategies targeting both “ancient” (e.g., pox, measles, and influenza) and invasive pathogens (e.g., zika and dengue) are required, but also new vaccination strategies focusing on humans and animals, from the perspective of the One Health approach. Moreover, in such a context, vaccine hesitancy threatens achieving adequate vaccination coverage worldwide.
The present SI will, therefore, welcome observational and interventional studies, along with systematic reviews and meta-analyses, addressing the topics of vaccines, vaccination strategies, emerging pathogens, infection control, and vaccine hesitancy.
Dr. Renata Gili
Dr. Davide Gori
Dr. Matteo Riccò
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine
- vaccination strategy
- one health
- emerging pathogens
- vaccine hesitancy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
